Рынок стартапов
← Все стартапы
Indee Labs

Indee Labs

YCW17

Enabling T cell immunotherapy discovery, development and manufacturing

/ 100
О компании

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Команда
5 чел.
Статус
Active